Modulation of human monocyte activities by tranilast, SB 252218, a compound demonstrating efficacy in restenosis

scientific article published on 01 December 2000

Modulation of human monocyte activities by tranilast, SB 252218, a compound demonstrating efficacy in restenosis is …
instance of (P31):
scholarly articleQ13442814

External links are
P698PubMed publication ID11082441

P2093author name stringT Smith
K M Anderson
L A Marshall
A K Roshak
D L Dewitt
B J Bolognese
E A Capper
P L Podolin
P433issue3
P407language of work or nameEnglishQ1860
P304page(s)1061-1069
P577publication date2000-12-01
P1433published inJournal of Pharmacology and Experimental TherapeuticsQ1500272
P1476titleModulation of human monocyte activities by tranilast, SB 252218, a compound demonstrating efficacy in restenosis
P478volume295

Reverse relations

cites work (P2860)
Q37070174ALOX5AP variants are associated with in-stent restenosis after percutaneous coronary intervention
Q47224466Alginate-liposomal construct for bupivacaine delivery and MSC function regulation.
Q34894514Suppression of matrix metalloproteinase production in nasal fibroblasts by tranilast, an antiallergic agent, in vitro
Q46470767Tranilast ameliorates impaired hepatic functions in Schistosoma mansoni-infected mice
Q52659646Tranilast directly targets NLRP3 to treat inflammasome-driven diseases.

Search more.